HIV Testing Every 3 Months for PrEP Patients

Table of Contents

• Why HIV Testing Every 3 Months Matters for PrEP Patients
• Building Your HIV Test Overdue Report from the EHR
  • Define Your Population
  • Set Your Overdue Thresholds
  • Exclude Scanned PDFs and Unstructured Results
• PrEP Follow-Up Monitoring Schedule by Regimen
• Setting Up a PrEP Patient Recall Workflow
  • Assign an Outreach Owner
  • Establish a Monthly Pull Cadence
• HIPAA-Compliant Patient Outreach for Overdue Testing
  • Validate the Record First
  • Outreach Scripts and Escalation Cadence
  • Bilingual and Equitable Outreach
  • Tracking Outreach and Escalation
• Monitoring for HIV Infection While on PrEP
• Tracking Compliance and Program Performance
• Frequently Asked Questions

Last Updated: October 10, 2026

Why HIV Testing Every 3 Months Matters for PrEP Patients

HIV testing PrEP patients every 3 months is not optional, it's the clinical floor that separates effective prevention from liability. When a patient starts oral PrEP, the 90-day testing interval (with STI screening and renal function checks) is the standard of care. Miss that window and the clinic loses visibility into treatment failure, acute infection, or medication non-adherence. The consequence is real: a patient on PrEP who seroconverts without a documented test becomes a clinical and legal exposure.

The problem is silent drift: patients miss appointments, lab orders sit unsigned, scanned PDFs never enter the structured data layer. In our experience, roughly half of a PrEP population in one practice of 1,700 patients was overdue on HIV testing PrEP patients at any given time.

Building Your HIV Test Overdue Report from the EHR

Most EHRs let you filter by medication class and lab result dates. The work is defining what counts and what doesn't.

Define Your Population

Start with two groups:

• Active PrEP patients: Anyone with an oral or injectable PrEP medication on the active med list (CPT codes Z29.81 for oral, J0739 for cabotegravir injection)
• Recently tested patients: Anyone with an HIV test result in the last 12 months, even if PrEP is not yet active

Both groups need monitoring: the first is under active follow-up; the second may be in intake or disengaged.

Set Your Overdue Thresholds

Use this table to classify patient status:

The 90-day mark is not arbitrary: oral PrEP requires HIV testing every 3 months to confirm negative status before refill. Injectable PrEP (Apretude or Yeztugo) follows month 1, month 2, then every 2 months, same principle, different cadence.

Exclude Scanned PDFs and Unstructured Results

Many clinics receive lab results as scanned PDFs or faxes that live in the chart but not in the structured lab table, making them invisible to reports.

Before pulling the overdue list, audit your lab-result storage: check the structured lab table for test type, date, and result value; exclude results that exist only as images or unstructured notes; manually update or flag any recent scanned results. Only structured results count, if the result is not in the lab table, it is invisible to reports and recall.

PrEP Follow-Up Monitoring Schedule by Regimen

Oral and injectable PrEP have different cadences, and both require HIV testing at every visit. The billing and documentation pathway determines whether that test reaches your structured lab table, and whether your overdue report will catch it.

Oral PrEP (tenofovir/emtricitabine):

• Every 3 months: HIV Ag/Ab test (CPT 86703 or 87389 QW), STI screening (gonorrhea, chlamydia, syphilis), clinical visit
• Every 6-12 months: Renal function (creatinine, eGFR)
• Before each refill: Confirm negative HIV status and code the visit as preventive (Z29.81, Z11.3, or Z11.4, never diagnostic)
• Billing: Bill the test and visit in-network under the patient's insurance; ACA section 2713 mandates $0 cost-sharing for USPSTF Grade A preventive services when coded correctly

Injectable PrEP (Apretude, cabotegravir; Yeztugo, lenacapavir):

• Month 1 and Month 2: Visits with HIV testing (4th-generation Ag/Ab with reflex RNA, CPT 86703 or 87389 QW)
• Then every 2 months (Apretude) or every 6 months (Yeztugo): Injection, HIV test, STI screen
• Renal monitoring: Every 6 months
• Billing: Bill the drug (J0739 for cabotegravir) with the administration code (96372) on the same claim under Z29.81; decide whether to bill the rapid test (86703 or 87389 QW with Z11.4)
• Critical documentation gap: The most common failure is an injection given at an appointment that was never checked in. If there is no encounter, there is no charge, no note, and no lab result in the structured table. Standardize an injection order set in your EHR and require staff to document the site, lot number, expiration date, HIV result, and kit lot in the encounter note, not in a separate staff case or paper log.

For pregnant patients or those planning pregnancy:

• Apretude is contraindicated; switch to oral PrEP
• Yeztugo lead-in then every 6 months; consult OB/GYN on drug interactions and coding (preventive vs. diagnostic)
• Every trimester: HIV test and STI screen

Why this matters for your overdue list: In our experience, TPA prescriber configs can drift. For example, in one audit, roughly a third of active rendering providers were missing because mid-levels rendered under a supervising NPI or the EHR carried the wrong NPI. Reconcile your TPA prescriber config against an EHR claims report by rendering NPI every quarter and list supervised providers under both their own NPI and their supervising NPI.

:::key takeaway Every prescriber owns follow-up of their open lab orders weekly. If a test was ordered but never collected, the order expires and the patient drifts overdue silently. Assign a named owner to audit unsigned or expired orders monthly and renew them before they age out.

Setting Up a PrEP Patient Recall Workflow

The monthly pull is useless without a workflow. Assign an owner, set a cadence, and build outreach into the clinic calendar.

Assign an Outreach Owner

Name one person. Not "the team." One person who owns the overdue list every single month.

This person pulls the report on the same date each month, reviews for data errors (scanned results, wrong NPI, lab delays), segments by status, and executes outreach or escalates to clinician. Without a named owner, the list gets pulled, filed, and forgotten.

Establish a Monthly Pull Cadence

Run the report the same day every month on a standing calendar block. Track total PrEP population, percent current (0-76 days), percent due-soon (77-90 days), percent overdue (91+ days), and percent never-tested. If overdue numbers stay above 20%, outreach is not working; if they climb, the program is losing control.

HIPAA-Compliant Patient Outreach for Overdue Testing

Outreach must protect PHI and be smart: not every overdue flag is real. Validate the record before contacting the patient to avoid duplicate outreach and false escalations.

Book a Free Strategy Call →

Validate the Record First

Common scenarios that create false-positive overdue flags:

Outreach Scripts and Escalation Cadence

Segment by status and execute the appropriate cadence. All messaging must be HIPAA-safe: no mention of HIV, PrEP, test results, or diagnosis names on voicemail, SMS, or email.

Due-Soon (77-90 days):

• Day 1 (SMS): "Hi [First Name], it's time for your routine checkup at [Clinic Name]. Reply STOP to opt out. Reply to book."
• Day 3 (Email if SMS bounces): "Your 3-Month Wellness Visit Is Due. Click to book or call [scheduler phone]."
• Day 5 (Call if no response): "Hi [First Name], we'd like to schedule your routine visit. When works best?"
• Goal: Book before patient reaches overdue status.

Overdue (91+ days):

• Day 1 (SMS): "Hi [First Name], we need to see you to refill your medication. Reply to book or call [scheduler phone]."
• Day 3 (Call): "We need to see you to refill your medication. When can you come in?"
• Day 7 (Second contact): "Hi [First Name], we still need to see you. Call [scheduler phone] to book."
• Day 14 (Escalate to clinician): Flag chart; clinician reviews for barriers and considers holding refill pending test.
• Goal: Complete test or identify barrier within 14 days.

Never-Tested on PrEP:

• Day 1 (Call immediately): "Hi [First Name], we need to complete a baseline test before we can continue your medication. When can you come in this week?"
• Day 2 (If no answer, SMS): "Hi [First Name], we need to see you for a quick test. Call [scheduler phone] to book."
• Day 3 (Block refill): Notify patient: "We can't refill your medication until we complete the test. Call us to schedule."
• Goal: Test completed within 3 days.

Bilingual and Equitable Outreach

Bilingual outreach (English/Spanish, Haitian Creole in Miami-Dade and Broward) must use the same scripts in each language and cadence. Train staff to deliver consistently and document language used and response in the CRM.

Common barriers: transportation (offer mobile testing or convenient lab stops), work schedule (early morning, evening, weekend slots), cost (confirm $0 cost-sharing under ACA section 2713; offer clinic-funded rapid test if uninsured), stigma (emphasize routine language; offer telehealth first), language (provide materials in patient's preferred language).

Tracking Outreach and Escalation

Use a HIPAA-compliant CRM (VaultStream integrates with your EHR and SMS platform) to log date, time, method, response, and next action for every outreach attempt. Set automatic escalation: due-soon → overdue cadence by day 5; overdue → clinician by day 14; never-tested → block refill by day 3.

Monitoring for HIV Infection While on PrEP

Testing is the early warning system for treatment failure. If a patient on PrEP tests positive, stop medication immediately and send for confirmatory testing (4th-generation Ag/Ab with reflex RNA). A discordant result suggests acute infection; repeat within 24-48 hours. A confirmed positive triggers linkage to care via an HIV treatment clinic (NexusBridge referral networks ensure seamless handoff). The testing interval also catches non-adherence; restart PrEP only after negative confirmatory test and an adherence plan.

Tracking Compliance and Program Performance

Report monthly on the overdue list. Share the data with the medical director and the practice administrator.

Key metrics:

• Percent of PrEP population current on testing (target: >80%)
• Average days since last test (target: <60 days)
• Time to outreach completion (target: <7 days from due-soon threshold)
• No-show rate for scheduled tests (target: <20%)
• Positive test rate (should be rare; >1% signals a program issue)

Use VaultStream or a similar HIPAA-compliant CRM to track outreach attempts, responses, and test results. Connect the outreach pipeline to the EHR so that booked appointments and completed tests flow back into the patient record automatically. This closes the loop and prevents duplicate outreach.

Report these metrics to leadership quarterly. If the overdue rate is climbing, the program needs more staff, better automation, or a workflow redesign.

Pulling an HIV test overdue list every month is the difference between a PrEP program that works and one that drifts. Assign an owner, set a cadence, validate the data, and reach out before the patient becomes a liability. The work is unglamorous, it is also the foundation of everything else.

Ready to automate this workflow and connect it to your EHR? The Marketing Lab offers a free 30-minute strategy call to walk through your current PrEP operations, identify gaps in testing compliance, and show how VaultStream integrates overdue lists with two-way SMS outreach and appointment booking. Book a time that works for your team.